Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Guérin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study

Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Guérin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study

Abstract Purpose To evaluate and compare the effectiveness and safety of hyperthermic intravesical chemotherapy (HIVEC) utilizing pirarubicin (THP) and Bacillus Calmette-Guérin (BCG) in the treatment of individuals diagnosed with high-risk non-muscle-invasive bladder cancer (NMIBC). Materials and me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhilong Huang, Shibo Huang, Eran Wu, Qinghua He, Xuedong Wei, Weiming Liang
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	BMC Urology
Subjects:	Non-muscle-invasive bladder cancer (NMIBC) Pirarubicin (THP) Hyperthermic intravesical chemotherapy (HIVEC) Hyperthermia Intravesical chemotherapy
Online Access:	https://doi.org/10.1186/s12894-025-01773-z
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

3-year experience of hyperthermic intravesical chemotherapy use in patients with high risk non-muscular-invasive bladder cancer
by: R.S. Chystiakov, et al.
Published: (2023-06-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
by: Mohammad Alghafees, et al.
Published: (2025-01-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Predictive value of tumor invasion patterns on intravesical bacillus Calmette–Guérin response for stage T1 high-grade non-muscle-invasive bladder cancer
by: Ismail Ulus, et al.
Published: (2025-07-01)

How Accurately Can Urologists Predict Eligible Patients for Immediate Postoperative Intravesical Chemotherapy in Bladder Cancer?
by: Hüseyin Alperen Yıldız, et al.
Published: (2025-07-01)

Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guérin
by: Seong Jong Eun, et al.
Published: (2020-08-01)

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
by: Boyan Atanasov, et al.
Published: (2022-06-01)

Intravesical Migration and Calcification of Intrauterin Device: A Case Report and Review of the Literature
by: Levent Verim, et al.
Published: (2015-12-01)

Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model
by: Ying Xu, et al.
Published: (2024-12-01)

Magnetic beads as intravesical foreign bodies in children: our clinical experience
by: Yefeng Zeng, et al.
Published: (2025-01-01)

Intravesical delivery of mucoadhesive and tumor-selective-penetrating nanozymes for enhancing the PDT of bladder cancer
by: Yang Liu, et al.
Published: (2025-08-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

Intravesical foreign bodies in pediatric: A case report highlighting the critical role of psychosocial assessment and intervention
by: Frincia Bunga Rante Allo, et al.
Published: (2025-03-01)

Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01)

Intravesical Tumor-Selective Mucoadhesive Hydrogel for Effective Chemotherapy In Murine Model
by: Zheng B, et al.
Published: (2025-06-01)

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
by: Jiwoong Yu, et al.
Published: (2023-11-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)

Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract
by: Lucía García-Morales, et al.
Published: (2024-11-01)

Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
by: Orlane Figaroa, et al.
Published: (2025-06-01)

The effectiveness of intravesical oxybutynin in the management of overactive bladder: a clinical study
by: Shoeb Alahmad, et al.
Published: (2024-12-01)

Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review
by: Hany Hasan Elsayed, et al.
Published: (2025-04-01)

Patients with small prostates and low-grade intravesical prostatic protrusion – A urodynamic evaluation
by: Han Jie Lee, et al.
Published: (2017-10-01)

Aortic endograft infection with Mycobacterium bovis following intravesical BCG immunotherapy diagnosed via the Karius Test™- case report and review of literature
by: Prateek Sharma, et al.
Published: (2025-06-01)

Harnessing intracellular bacteria in bladder by intravesical delivery of antibiotics-loaded nanodiamonds to reduce the recurrence of urinary tract infection
by: Carmen Oi Kwan Law, et al.
Published: (2025-05-01)

Correlation of Intravesical Prostatic Protrusion with Severity of Lower Urinary Tract Symptoms in Men With Symptomatic Benign Prostatic Hyperplasia at University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu
by: Chukwunonso Anthony Iwenofu, et al.
Published: (2024-10-01)

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS
by: A. A. Zakharenko, et al.
Published: (2017-12-01)

Dual-source powered sea urchin-like nanomotors for intravesical photothermal therapy of bladder cancer
by: Yixuan Mou, et al.
Published: (2025-05-01)

Intravesical migration of intrauterine device: Case report and literature review
by: Gamal M. Ghoniem, et al.
Published: (2024-12-01)

PREVENTION OF RECURRENCE AFTER ORGAN-SAVING SURGERY OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
by: T. A. Sveklina, et al.
Published: (2013-03-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience
by: Burak Dinçer, et al.
Published: (2025-03-01)

Transcriptomic Profiles for Elucidating Response of Bladder Intracavitary Hyperthermic Perfusion Chemotherapy in High‐Risk Nonmuscular Invasive Bladder Cancer
by: Zhicheng Huang, et al.
Published: (2025-02-01)

A COMPLETE DUPLICATED SYSTEM WITH INTRAVESICAL URETEROCELE IN A 60-YEARS-OLD WOMAN: A CASE REPORT
by: Satria Adji Hady Prabowo, et al.
Published: (2025-05-01)

Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
by: Yongheng Zhou, et al.
Published: (2025-04-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
by: Amandeep Arora, et al.
Published: (2025-06-01)

Pediatric papillary urothelial neoplasm: 18-year single-center experience in diagnosis and treatment
by: Pei Liu, et al.
Published: (2025-06-01)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
by: Raymond Hayler, et al.
Published: (2025-07-01)

Is Cystoscopic Intravesical Injection of OnabotulinumtoxinA Acceptable in an Outpatient Clinic?
by: Thomas James Curtis, et al.
Published: (2025-03-01)

Investigation of Therapeutic Efficacy of Intravesical Tigecycline Administration in Rats with Cystitis Induced by Extensively Drug-Resistant (XDR), Tigecycline-Sensitive <i>Acinetobacter baumannii</i> Strain
by: Cihan Yüksel, et al.
Published: (2025-06-01)